Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1959 Aug;38(8):1366–1375. doi: 10.1172/JCI103912

COMBINED DRUG TREATMENT OF TUBERCULOSIS. III. CLINICAL APPLICATION OF THE PRINCIPLES OF APPROPRIATE AND ADEQUATE CHEMOTHERAPY TO THE TREATMENT OF PULMONARY TUBERCULOSIS

William F Russell Jr 1,2,3, Irving Kass 1,2,3, Angeline D Heaton 1,2,3, Sidney H Dressler 1,2,3, Gardner Middlebrook 1,2,3
PMCID: PMC442091  PMID: 13673093

Full text

PDF
1366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELL J. W. The problem of resection surgery for pulmonary tuberculosis in the noninfectious patient with persisting cavitary disease. Am Rev Tuberc. 1956 Aug;74(2 Pt 1):169–177. doi: 10.1164/artpd.1956.74.2-1.169. [DOI] [PubMed] [Google Scholar]
  2. CARLSON H. B., ANTHONY E. M., RUSSELL W. F., Jr, MIDDLEBROOK G. Prophylaxis of isoniazid neuropathy with pyridoxine. N Engl J Med. 1956 Jul 19;255(3):119–122. doi: 10.1056/NEJM195607192550304. [DOI] [PubMed] [Google Scholar]
  3. COHN M. L., MANDEL W., MIDDLEBROOK G., RUSSELL W. F., Jr Serum isoniazid levels and catalase activities of tubercle bacilli from isoniazid-treated patients. Am J Med Sci. 1957 Jan;233(1):66–68. doi: 10.1097/00000441-195701000-00011. [DOI] [PubMed] [Google Scholar]
  4. COHN M. L., MIDDLEBROOK G., RUSSELL W. F., Jr Combined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J Clin Invest. 1959 Aug;38(8):1349–1355. doi: 10.1172/JCI103910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CROFTON J. Sputkm conversion and the metabolism of isoniazid. Am Rev Tuberc. 1958 May;77(5):869–871. doi: 10.1164/artpd.1958.77.5.869. [DOI] [PubMed] [Google Scholar]
  6. HEATON A. D., RUSSELL W. F., Jr, DENST J., MIDDLEBROOK G. Combined drug treatment of tuberculosis. IV. Bacteriologic studies on the sputum and resected pulmonary lesions of tuberculous patients. J Clin Invest. 1959 Aug;38(8):1376–1383. doi: 10.1172/JCI103913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KASS I., RUSSELL W. F., Jr, HEATON A., MIYAMOTO T., MIDDLEBROOK G., DRESSLER S. H. Changing concepts in the treatment of pulmonary tuberculosis. Ann Intern Med. 1957 Oct;47(4):744–761. doi: 10.7326/0003-4819-47-4-744. [DOI] [PubMed] [Google Scholar]
  8. MANDEL W., COHN M. L., RUSSELL W. F., Jr, MIDDLEBROOK G. Effect of para-aminosalicylic acid on serum isoniazid levels in man. Proc Soc Exp Biol Med. 1956 Mar;91(3):409–411. doi: 10.3181/00379727-91-22278. [DOI] [PubMed] [Google Scholar]
  9. MANDEL W., HEATON A. D., RUSSELL W. F., Jr, MIDDLEBROOK G. Combined drug treatment of tuberculosis. II. Studies of antimicrobially-active isoniazid and streptomycin serum levels in adult tuberculous patients. J Clin Invest. 1959 Aug;38(8):1356–1365. doi: 10.1172/JCI103911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MIDDLEBROOK G., COHN M. L. Bacteriology of tuberculosis: laboratory methods. Am J Public Health Nations Health. 1958 Jul;48(7):844–853. doi: 10.2105/ajph.48.7.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. MIDDLEBROOK G., COHN M. L., SCHAEFER W. B. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc. 1954 Nov;70(5):852–872. doi: 10.1164/art.1954.70.5.852. [DOI] [PubMed] [Google Scholar]
  13. ROSS J. D., HORNE N. W., GRANT I. W., CROFTON J. W. Hospital treatment of pulmonary tuberculosis; a follow-up study of patients admitted to Edinburgh hospitals in 1953. Br Med J. 1958 Feb 1;1(5065):237–242. doi: 10.1136/bmj.1.5065.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. RUSSELL W. F., Jr, DRESSLER S. H., MIDDLEBROOK G. Chemotherapy of tuberculosis. Adv Intern Med. 1956;8:221–257. [PubMed] [Google Scholar]
  15. RYDER J. B. Prognosis of persistent cavitation in sputum-negative cases of tuberculosis following long-term chemotherapy. Tubercle. 1958 Apr;39(2):113–115. doi: 10.1016/s0041-3879(58)80029-x. [DOI] [PubMed] [Google Scholar]
  16. SCHAEFER W. B., COHN M. L., MIDDLEBROOK G. The role of biotin and carbon dioxide in the cultivation of Mycobacterium tuberculosis. J Bacteriol. 1955 Jun;69(6):706–712. doi: 10.1128/jb.69.6.706-712.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SCHAEFER W. B. The effect of isoniazid on growing and resting tubercle bacilli. Am Rev Tuberc. 1954 Jan;69(1):125–127. doi: 10.1164/art.1954.69.1.125. [DOI] [PubMed] [Google Scholar]
  18. STEWART S. M. Virulence of tubercle bacilli recovered from patients treated with isoniazid. Am Rev Tuberc. 1954 Apr;69(4):641–644. [PubMed] [Google Scholar]
  19. WILSON T. M., DOYLE L., GARDINER M. P. Open healing of tuberculous cavities; results in 40 patients treated conservatively. Br Med J. 1958 Jul 12;2(5088):87–90. doi: 10.1136/bmj.2.5088.87. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES